Product image of Norditropin Flexpro (Somatropin) supplied by GNH India

Norditropin Flexpro

Active Ingredient:
Somatropin
Origin:
EU

Norditropin Flexpro (Somatropin)

Somatropin, the active ingredient in Norditropin Flexpro, is a growth hormone presented as a recombinant protein for subcutaneous use. It is prescribed to treat growth hormone deficiency and related growth disorders in children and adults, helping to normalize growth and metabolic processes.

GNH India supplies Norditropin Flexpro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable cold‑chain logistics for biologic products, ensuring product integrity from manufacture to delivery.

Manufacturer / TM Owner

Novo Nordisk Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Norditropin Flexpro (somatropin) is used in endocrine therapy to address conditions characterized by insufficient endogenous growth hormone.

  • Growth hormone deficiency: Improves linear growth in children and restores normal metabolic function in adults with GH deficiency.
  • Turner syndrome: Increases height velocity and helps achieve near‑normal adult stature in girls with this chromosomal disorder.
  • Prader‑Willi syndrome: Enhances growth and body composition, supporting better physical development in affected individuals.
  • Chronic renal insufficiency: Promotes growth in pediatric patients with renal disease where GH deficiency contributes to short stature.

How It Works

  • Somatropin binds to growth‑hormone receptors on target cells, activating the JAK2‑STAT5 signaling cascade. This stimulates hepatic production of insulin‑like growth factor‑1 (IGF‑1) and modulates protein, lipid and carbohydrate metabolism. The increased IGF‑1 mediates most of the anabolic and growth‑promoting effects, while direct GH actions also influence bone growth and muscle development.

Side Effects

Somatropin may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Injection site pain: mild discomfort or erythema at the injection site.
  • Headache: transient headache reported in some patients.
  • Joint stiffness: occasional arthralgia or reduced joint mobility.
  • Edema: peripheral swelling, especially in the lower extremities.
  • Hyperglycemia: elevated blood glucose levels, particularly in predisposed individuals.

Serious or Rare Side Effects

  • Intracranial hypertension: signs include severe headache, visual disturbances, and papilledema.
  • Slipped epiphysis: premature closure of growth plates leading to bone deformities.
  • Allergic reactions: rash, urticaria, or anaphylaxis in rare cases.
  • Pancreatitis: acute inflammation of the pancreas presenting with abdominal pain.

Precautions & Warnings

Prior to initiating Norditropin Flexpro, clinicians should consider several safety measures to minimize risks.

  • Monitor IGF‑1 levels: adjust dose based on serial measurements to avoid excess exposure.
  • Screen for diabetes: assess fasting glucose and HbA1c before and during therapy.
  • Evaluate for intracranial hypertension: watch for persistent headaches or visual changes.
  • Avoid in active malignancy: growth hormone may stimulate tumor growth.
  • Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Somatropin can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Glucocorticoids: may blunt the anabolic effects of growth hormone.
  • Insulin: somatropin can reduce insulin sensitivity, requiring dose adjustments.
  • Oral estrogen therapy: can diminish IGF‑1 response, potentially reducing efficacy.

Moderate Interactions (Monitor Closely)

  • Thyroid hormone replacement: GH therapy may increase thyroid hormone requirements.
  • Diuretics: may exacerbate fluid retention and edema.
  • Antidiabetic agents: monitor glucose control as GH may raise blood sugar.

Frequently Asked Questions

Norditropin Flexpro contains somatropin, a recombinant human growth hormone indicated for patients with growth hormone deficiency and related growth disorders. It is used to promote linear growth in children and to improve metabolic parameters in adults who lack adequate endogenous growth hormone.

Somatropin binds to specific growth‑hormone receptors on target cells, triggering intracellular signaling that increases production of insulin‑like growth factor‑1 (IGF‑1). IGF‑1 drives the anabolic processes responsible for bone growth, protein synthesis, and metabolic regulation, thereby correcting the deficits caused by growth hormone deficiency.

The dose of Norditropin Flexpro is individualized and set by the prescribing healthcare professional based on factors such as age, weight, severity of deficiency, IGF‑1 levels, and treatment response. No fixed dosing regimen can be provided without a medical assessment.

Safety data for somatropin in pregnancy and lactation are limited. It is generally advised to avoid use during pregnancy unless the potential benefit outweighs the risk, and breastfeeding mothers should consult their physician before initiating therapy.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain logistics if needed) and the necessary import documentation.

Norditropin Flexpro is a recombinant human growth hormone similar in molecular structure to other GH products. Differences lie mainly in the delivery device and formulation stability. Clinical efficacy and safety are comparable when used according to prescribing information, but selection may depend on patient preference, dosing convenience and supply chain considerations.

Norditropin Flexpro should be stored in a refrigerator at 2 °C to 8 °C. Keep the vial in its original packaging, protect it from direct light, and avoid freezing or shaking the product. If a short period at room temperature is unavoidable, follow the manufacturer’s guidance on maximum exposure time.

The product is administered by subcutaneous injection, typically into the thigh, abdomen or upper arm. Patients or caregivers should rotate injection sites, use aseptic technique, and follow the specific instructions provided by the prescriber or the product’s administration guide.

Serious adverse events include intracranial hypertension, which may present with severe headache and visual changes, slipped epiphysis (premature closure of growth plates), severe allergic reactions such as anaphylaxis, and pancreatitis. Prompt medical evaluation is required if any of these symptoms occur.

Norditropin Flexpro is contraindicated in individuals with known hypersensitivity to somatropin or any excipients, and it should be avoided in patients with active malignancy, uncontrolled diabetes, or severe acute illness where growth hormone therapy could be harmful.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Somatropin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT